Archer Investment Corp - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Archer Investment Corp ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,200
+5.9%
1,0000.0%0.01%0.0%
Q2 2023$36,070
-5.6%
1,0000.0%0.01%
-7.1%
Q1 2023$38,190
-32.9%
1,0000.0%0.01%
-36.4%
Q4 2022$56,900
-99.9%
1,0000.0%0.02%
+29.4%
Q3 2022$39,540,000
-10.1%
1,0000.0%0.02%
-5.6%
Q2 2022$44,000,000
+6.3%
1,0000.0%0.02%
+20.0%
Q1 2022$41,380,000
+2.9%
1,0000.0%0.02%
+7.1%
Q4 2021$40,210,000
-1.2%
1,0000.0%0.01%
-6.7%
Q3 2021$40,680,000
-10.4%
1,0000.0%0.02%
-16.7%
Q2 2021$45,410,000
+8.9%
1,0000.0%0.02%
+5.9%
Q1 2021$41,690,000
-2.4%
1,0000.0%0.02%
-15.0%
Q4 2020$42,710,000
+62.5%
1,0000.0%0.02%
+42.9%
Q3 2020$26,280,000
-2.0%
1,0000.0%0.01%
-6.7%
Q2 2020$26,810,000
+148844.4%
1,0000.0%0.02%
+25.0%
Q1 2020$18,0000.0%1,0000.0%0.01%
+20.0%
Q4 2019$18,000
+12.5%
1,0000.0%0.01%0.0%
Q3 2019$16,000
-5.9%
1,0000.0%0.01%
-9.1%
Q2 2019$17,000
+6.2%
1,0000.0%0.01%0.0%
Q1 2019$16,000
+6.7%
1,0000.0%0.01%
-15.4%
Q4 2018$15,0001,0000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders